title: Helicobacter infection decreases reproductive performance of IL10-deficient mice.
abstract: Infections with a variety of Helicobacter species have been documented in rodent research facilities, with variable effects on rodent health. Helicobacter typhlonius has been reported to cause enteric disease in immunodeficient and IL10(-/-) mice, whereas H. rodentium has only been reported to cause disease in immunodeficient mice coinfected with other Helicobacter species. The effect of Helicobacter infections on murine reproduction has not been well studied. The reproductive performance of C57BL/6 IL10(-/-) female mice intentionally infected with H. typhlonius, H. rodentium, or both was compared with that of age-matched uninfected controls or similarly infected mice that received antihelicobacter therapy. The presence of Helicobacter organisms in stool and relevant tissues was detected by PCR assays. Helicobacter infection of IL10(-/-) female mice markedly decreased pregnancy rates and pup survival. The number of pups surviving to weaning was greatest in noninfected mice and decreased for H. rodentium > H. typhlonius >> H. rodentium and H. typhlonius coinfected mice. Helicobacter organisms were detected by semiquantitative real-time PCR in the reproductive organs of a subset of infected mice. Treatment of infected mice with a 4-drug regimen consisting of amoxicillin, clarithromycin, metronidazole, and omeprazole increased pregnancy rates, and pup survival and dam fecundity improved. We conclude that infection with H. typhlonius, H. rodentium, or both decreased the reproductive performance of IL10(-/-) mice. In addition, antihelicobacter therapy improved fecundity and enhanced pup survival.
authors.affiliation: Office of Animal Welfare Assurance, Duke University Medical Center, Durham, NC, USA.
authors.forename: Julie M
authors.initials: JM
authors.lastname: Sharp
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Vanderford
authors.forename: Maciej
authors.initials: M
authors.lastname: Chichlowski
authors.forename: Matthew H
authors.initials: MH
authors.lastname: Myles
authors.forename: Laura P
authors.initials: LP
authors.lastname: Hale
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004269:DNA, Bacterial / Q000302:isolation & purification; D005260:Female; D005298:Fertility; D016998:Helicobacter / Q000235:genetics / Q000302:isolation & purification* / Q000472:pathogenicity; D016481:Helicobacter Infections / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology* / Q000635:transmission / Q000662:veterinary; D018445:Infectious Disease Transmission, Vertical; D016753:Interleukin-10 / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010053:Ovary / Q000382:microbiology / Q000503:physiopathology; D011247:Pregnancy; D012098:Reproduction / Q000187:drug effects; D012376:Rodent Diseases / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology*; D014599:Uterus / Q000382:microbiology / Q000503:physiopathology
chemical_list: D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D016753:Interleukin-10